How might K-PAX work to prevent lipodystrophy?
Lipodystrophy can be defined as changes in body fat and appearance often associated with HIV infection and/or its treatment. Sometimes these changes may involve the loss of fat in the face and/or extremities (lipoatrophy) while at other times these changes may involve an abnormal accumulation of fat in the abdomen or neck region. Lipodystrophy has been shown in several research studies to be caused in part by antiviral drug toxicity to the mitochondria of fat cells as well as by HIV infection itself. By providing high dosages of potent antioxidants, K-PAX Immune Support Formula may help fat cells resist the oxidation and premature death that can lead to lipodystrophy.
